In their closing thoughts, the expert panelists discuss the future of the disease state and treatment options, and how they expect provider, patient, and payer value perception to change in the future ...

Following the successful late-stage study in wet age-related macular degeneration, Ocular plans to meet with the FDA to ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

STOCKHOLM — Current treatments for age-related macular degeneration (AMD) have proven effective and safe. However, these lifelong therapies involve frequent ocular injections. "It can be ...

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the ...

Age-related macular degeneration (AMD) is a leading cause of vision loss among people aged 50 and older. While treatments for the wet form of AMD have shown promise, the dry form, which accounts for ...

The company is set to release topline results from its Phase 3 superiority trial of Axpaxli in wet AMD on Tuesday. ・Ocular ...

Outlook Therapeutics, Inc. has announced a key development in the treatment of wet age-related macular degeneration (wet AMD) with the National Institute for Health and Care Excellence (NICE) ...

4D Molecular Therapeutics' gene therapy, 4D-150, shows potential to reduce the treatment burden for patients with severe wet AMD. Interim findings from a Phase 2 trial demonstrate up to an 89% ...

Please provide your email address to receive an email when new articles are posted on . Crocus sativus, or saffron, is a safe and tolerable adjunct treatment for AMD, helping to improve visual ...

Share on Pinterest Researchers compared two drugs for treatment of wet age-related macular degeneration. Emilija Manevska/Getty Images About 170 million people globally live with age-related macular ...

Age-related macular degeneration (AMD) is a common reason people lose vision as they get older. It can make it hard to see things in detail. AMD can cause you to lose central vision over time.